Infectious complications after heart transplantation in Chinese recipients

American Journal of Transplantation

Volumn 5, Issue 8, 2005, Pages 2011-2016

  Hsu, Ron Bin ^a   Fang, Chi Tai ^a   Chang, Shan Chwen ^a   Chou, Nai Kuan ^a   Ko, Wen Je ^a   Wang, Shoei Shen ^a   Chu, Shu Hsun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chinese; Heart transplantation; Infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; CHILD; CHINESE; CYTOMEGALOVIRUS INFECTION; ETHNIC GROUP; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; INFECTION; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM TUBERCULOSIS; ORGAN TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL RATE; TAIWAN; VIRUS DISEASES;

EID: 22844452343     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00951.x     Document Type: Article

References (33)

1. Montoya JG, Giraldo LF, Efron B et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001; 33: 629-640.
2. Bobbins RC, Barlow CW, Oyer PE et al. Thirty years of cardiac transplantation at Stanford university. J Thorac Cardiovasc Surg 1999; 117: 939-951.
3. Brann WM, Bennett LE, Keck BM, Hosenpud JD. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 1998; 17: 374-382.
4. Miller LW, Naftel DC, Bourge RC et al. Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994; 13: 381-392.
5. Gentry LO. Cardiac transplantation and related infections. Semin Respir Infect 1993; 8: 199-206.
6. Smart FW, Naftel DC, Costanzo MR et al. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1996; 15: 329-341.
7. Hsu RB, Chu SH, Wang SS et al. Low incidence of transplant coronary artery disease in Chinese heart recipients. J Am Coll Cardiol 1999; 33: 1573-1577.
8. Cisneros JM, Munoz P, Torre-Cisneros J et al. Pneumonia after heart transplantation: a multi-institutional study. Spanish Transplantation Infection Study Group. Clin Infect Dis 1998; 27: 324-331.
9. Waser M, Maggiorini M, Luthy A et al. Infectious complications in 100 consecutive heart transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13: 12-18.
10. Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. J Heart Lung Transplant 1992; 11: 847-866.
11. Torre-Cisneros J, Caston JJ, Moreno J et al. Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation 2004; 77: 1376-1380.
12. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27: 1266-1277.
13. Aguado JM, Herrero JA, Gavalda J et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63: 1278-1286.
14. Cavusoglu C, Cicek-Saydam C, Karasu Z et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients. Clin Transplant 2002; 16: 257-261.
15. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215.
16. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 1148-1153.
17. Yildiz A, Sever MS, Turkmen A et al. Tuberculosis after renal transplantation: experience of one Turkish centre. Nephrol Dial Transplant 1998; 13: 1872-1875.
18. Lee J, Lee MH, Kim WS et al. Tuberculosis in hematopoietic stem cell transplant recipients in Korea. Int J Hematol 2004; 79: 185-188.
19. Ku SC, Tang JL, Hsueh PR, Luh KT, Yu CJ, Yang PC. Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1293-1297.
20. Korner MM, Hirata N, Tenderich G et al. Tuberculosis in heart transplant recipients. Chest 1997; 111: 365-369.
21. Yu MC, Suo J, Huang C, Bai KJ, Lin TP, Luh KT. Annual risk of tuberculous infection in Taiwan, 1996-1998. J Formos Med Assoc 1999; 98: 496-499.
22. Kirklin JK, Naftel DC, Levine TB et al. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994; 13: 394-404.
23. Fishman JA. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis 2001; 33: 1397-1405.
24. Olsen SL, Renlund DG, O'Connell JB et al. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation 1993; 56: 359-362.
25. Munoz P, Munoz RM, Palomo J, Rodriguez-Creixems M, Munoz R, Bouza E. Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. Medicine 1997; 76: 415-422.
26. Roblot F, Le Moal G, Godet C et al. Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study. J Infect 2003; 47: 19-27.
27. Gordon SM, LaRosa SP, Kalmadi S et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999; 28: 240-246.
28. Cardenal R, Medrano FJ, Varela JM et al. Pneumocystis carinii pneumonia in heart transplant recipients. Eur J Cardiothorac Surg 2001; 20: 799-802.
29. Hung CC, Chen MY, Hsieh SM, Sheng WH, Chang SC. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr 2000; 24: 378-385.
30. Radisic M, Lattes R, Chapman JF et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis 2003; 5: 84-93.
31. Grossi P, Ippoliti GB, Goggi C, Cremaschi P, Scaglia M, Minoli L. Pneumocystis carinii pneumonia in heart transplant recipients. Infection 1993; 21: 75-79.
32. Costanzo-Nordin MR, Swinnen LJ, Fisher SG et al. Cytomegalovirus infections in heart transplant recipients: relationship to immunosuppression. J Heart Lung Transplant 1992; 11: 837-846.
33. Arend SM, Westendorp RG, Kroon FP et al. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin Infect Dis 1996; 22: 920-925.